Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2031studies shown
Showing 13-24 of 2,031
Device study icon
RecruitingNCT07603804

Accelerated iTBS for Major Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Istanbul
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
Türkiye
Sponsor
Istanbul University - Cerrahpasa
Condition
Depression
Biological study icon
RecruitingNCT06542094

Identifying Local Field Potential Biomarkers for Treatment-Resistant Major Depression With Deep Brain Stimulation

This study is looking at whether a digital support tool can help people with depression or Treatment Resistant Depression. Participants take part in a digital support tool and complete follow-up assessments.

In Chengdu
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 65 Years
Countries
China
Sponsor
West China Hospital
Condition
Depression
Drug study icon
RecruitingNCT07139834

Pattern Separation in Major Depressive Disorder

This study is comparing SSRI (escitalopram or sertraline) with placebo for people with depression. Participants receive SSRI (escitalopram or sertraline) or placebo and complete study visits and assessments.

In New York
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 50 Years
Countries
United States
Sponsor
Jeffrey Miller
Condition
Depression
Drug study icon
RecruitingNCT05973851

The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

This study is recruiting in the United Kingdom, in Austria, in Germany, .... It focuses on depression.

Multiple locations, including Innsbruck
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United Kingdom, Austria, Germany, ...
Sponsor
Dr. Inge Winter
Condition
Depression
Drug study icon
RecruitingNCT07196501

Maintenance Effect of NBI-1065845 for depression

This study is recruiting in the United States, in Australia, in Canada, .... It is testing Maintenance Effect of NBI-1065845 for depression.

Multiple locations, including Oceanside
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States, Australia, Canada, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
RecruitingNCT07226661

Study in Adults With Major Depressive Disorder

This study is recruiting in the United States. It focuses on depression.

In Garden Grove
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
Depression
Drug study icon
RecruitingNCT06132178

Psilocybin rTMS for Treatment Resistant Depression

This study is comparing Psilocybin with Full dose COMP360 with sham aiTBS rTMS for people with Treatment Resistant Depression, Mdd, depression, or Recurrent Depression. Participants receive Psilocybin or Full dose COMP360 with sham aiTBS rTMS and complete study visits and assessments.

In Austin
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 22 Years to 65 Years
Countries
United States
Sponsor
University of Texas at Austin
Condition
Depression
Behavioral study icon
RecruitingNCT06793397

A Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

This study is recruiting in the United States, in Australia, in the United Kingdom, .... It is testing deuterated Psilocin Analog for depression.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 85 Years
Countries
United States, Australia, United Kingdom, ...
Sponsor
Cybin IRL Limited
Condition
Depression
Behavioral study icon
RecruitingNCT07284667

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

This study is comparing ACP-211 with placebo for people with depression or depression, Treatment-Resistant. Participants receive ACP-211 or placebo and complete study visits and assessments.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Depression
Behavioral study icon
RecruitingNCT07388004

Group Therapy for Major Depression: Comparing Expectation-Focused and Reward-Focused Psychotherapy Approaches

This study is comparing Expectation-Focused Psychotherapeutic Intervention with Waiting-List Control for people with depression. Participants receive Expectation-Focused Psychotherapeutic Intervention or Waiting-List Control and complete study visits and assessments.

In Marburg
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 80 Years
Countries
Germany
Sponsor
Philipps University Marburg
Condition
Depression
Device study icon
RecruitingNCT07228468

Home-Based Transcranial Direct Current Stimulation In Major Depressive Disorder (HOME)

This study is looking at whether transcranial direct current stimulation (tDCS) can help people with depression. Participants receive a study treatment and complete follow-up visits and assessments.

Multiple locations, including Cardiff
Why is this study shown?

This study is directly about Depression.

DepressionDeviceOver 18 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.